Drug Manufacturers - General
Stocks Ranked by
Market Capitalization

Name Market cap Price Price
change %
LLY icon
1
Eli Lilly
LLY
$852B
$852B $953.30 2.39%
JNJ icon
2
Johnson & Johnson
JNJ
$581B
$581B $241.30 1.21%
ABBV icon
3
AbbVie
ABBV
$374B
$374B $211.59 2.53%
AZN icon
4
AstraZeneca
AZN
$317B
$317B $204.27 1.72%
MRK icon
5
Merck
MRK
$305B
$305B $123.18 3.27%
NVS icon
6
Novartis
NVS
$295B
$295B $154.42 2.12%
AMGN icon
7
Amgen
AMGN
$189B
$189B $349.81 2.89%
GILD icon
8
Gilead Sciences
GILD
$176B
$176B $141.54 1.97%
NVO icon
9
Novo Nordisk
NVO
$167B
$167B $37.61 1.9%
PFE icon
10
Pfizer
PFE
$156B
$156B $27.47 1.37%
BMY icon
11
Bristol-Myers Squibb
BMY
$121B
$121B $59.20 2.65%
GSK icon
12
GSK
GSK
$115B
$115B $57.37 2.74%
SNY icon
13
Sanofi
SNY
$113B
$113B $47.14 0.66%
BIIB icon
14
Biogen
BIIB
$26.4B
$26.4B $179.90 2.44%
GRFS icon
15
Grifois
GRFS
$5.71B
$5.71B $8.39 3.58%
OGN icon
16
Organon & Co
OGN
$1.53B
$1.53B $5.86 4.25%
ARMP icon
17
Armata Pharmaceuticals
ARMP
$444M
$444M $12.12 1.42%
LCTX icon
18
Lineage Cell Therapeutics
LCTX
$384M
$384M $1.54 1.32%
AMRN
19
Amarin Corp
AMRN
$306M
$306M $14.73 0.27%
PLX icon
20
Protalix BioTherapeutics
PLX
$181M
$181M $2.25 2.74%
UNOV icon
21
Innovator US Equity Ultra Buffer ETF November
UNOV
$174M
$174M $37.98 1.25%
PTHS
22
Pelthos Therapeutics
PTHS
$76.8M
$76.8M $22.90 0.7%
IBO
23
Impact BioMedical
IBO
$76.6M
$76.6M $0.7100 6.07%
MAIA icon
24
MAIA Biotechnology
MAIA
$75.2M
$75.2M $1.24 3.33%
XTNT icon
25
Xtant Medical Holdings
XTNT
$65.9M
$65.9M $0.4702 3.11%